MISSISSAUGA (October, 2025) — Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, was named this year’s winner of The Bruce Power Award for Canada’s Safest New Employer. The award, announced during the 2025 Canada’s Safest Employers ceremony in October, recognizes an exemplary safety record in less than 10 years of operation.
Bora’s manufacturing facility in Mississauga approaches its five-year anniversary in December following its July expansion. The expansion, which added advanced filling technology to increase its annual production capacity to more than 50 million units, increased Bora’s ability to meet rising demand across a growing range of drug programs without sacrificing the Company’s dedication to safety.
“Our entire team in Mississauga is committed to upholding our standards as a global leader, and maintaining a strong focus on safety is central to those efforts,” said John Lawrie, Vice President of Operations at Bora. “We’re honored to receive the Bruce Power Award and will continue building on this achievement by reinforcing safety as the foundation for Bora’s global growth.”
Strong employee engagement and active participation in Environment, Health, and Safety (EHS) initiatives, reinforced by the support of Senior Leaders, have been instrumental in fostering Bora’s culture of safety. As Bora celebrates this milestone, the Mississauga site will remain a benchmark for safety performance and a source of best practices across Bora’s worldwide operations.
Bora is a global CDMO operating seven state-of-the-art facilities across North America and Asia. From early development and scale-up to process optimization and commercial manufacturing, Bora’s experienced teams support customers at every stage of the product lifecycle. For more information, visit boracdmo.com.
###
About Bora Pharmaceuticals
Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, biologics, and sterile injectable pharmaceutical products. From our world-class sites in North America and Asia, we deliver drug products with unparalleled quality to more than 100 markets around the world. For more information, visit www.boracdmo.com.